E-pharmacies divided over their legal status

India’s online pharmacy startups are a divided house. Two factions in the nascent e-pharmacy segment have taken diametrically opposite view on a public interest litigation that challenges the legality of these startups.

On Monday, the Madras High Court will hear a petition from Tamil Nadu Chemists and Druggists Association that has challenged the existence of e-pharmacies on the grounds that they are running in violation of the Drugs and Cosmetics Act.

Are online pharmacies intermediaries or a full-fledged pharmacy stores requiring a licence? This is the contention that the Madras HC will hear.

On one side are the online startups with a legacy in pharma business who think it is imperative for them to have a licence like a pharmacy shop. Pitted against them are those who think they are “Swiggy”, or mere deliverers, of medicine business and therefore don’t require one.

In October, the HC also granted a stay on suspension of operations of e-pharmacies that run without a licence. It is here where the start-ups have taken a different view. “There are two models, like Netmeds and M Chemist, who have a licence and the court says they can operate. Those with marketplace model (like 1mg and PharmEasy) say they are intermediaries who source from licensed pharmacies and hence do not need a license”, said Rajiv Gulati of E Pharmacy Association to ET.

Pradeep Dadha, founder of NetMeds, said that as a fully licensed pharmacy, it is committed to adhering to all the guidelines and rules under the Drugs & Cosmetics Act. Dadha added that he is “pleased” with outcome of the recent court hearing that said it will not restrict licensed e pharmacies from selling medicines on its platforms.

Like Netmeds, M Chemist and Medlife have licences. However startups like PharmEasy and 1Mg, who call themselves as intermediaries or a market place, are of the view that though they do not have a licence, the pharmacy chains through which they source and deliver medicines have one. “We explained to the court that we are an intermediary (Covered by the IT Act) and we ensure that all the vendors on our platform operate with the licence under the D&C Act”, said Prashant Tandon, founder of 1Mg, an e-pharmacy startup. As an intermediary platform, given they do not dispense medicines, the license required for dispensation for a pharmacy is not really applicable to them, says Tandon.

Tandon believes that legal entities should look at the draft rules for pharmacies released in September this year that indicated that all e-platforms should apply for a central registration.

The offline trader lobby, which is politically and financially powerful, see the entry of e-pharmacies as a threat and have waged legal battles in several courts to thwart the emergence of these startups, an industry official, who did not wish to be identified, said.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’